The PEAD projected a Bullish outlook for $DXCM after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 12.71%.
DexCom
Short Term - We look to Buy at 74.01 (stop at 60.52)
A bullish reverse Head and Shoulders is forming. This is positive for sentiment and the uptrend has potential to return. There is scope for mild selling at the open but losses should be limited. Support is located at 70.00 and should stem dips to this area. Dip buying offers good risk/reward.
Our...
In this case, AB is equal to CD, which is ideal but not always the case..
You can use the magnet and move the AB leg to the CD position to see if it fits. This pattern when bullish, looks like a downtrend and is sometimes found within a larger downtrend, so be safe. The bearish version would begin with AB, or leg 1 to the upside. In the bullish version, the AB...
I am just writing this in all of about 2 seconds since I was reminded this morning but some clueless guy who wants to take a fundamental approach to investing. He really isn't. He is just trying to sound like he has a clue to what he is doing and in reality, he is getting beating like a baseball during a Red Sox/ Yankees world series.
Dexcom... can anyone...
The PEAD projected a Bullish outlook for $DXCM after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 100%.
This is a short-term trade. On the technical side, we've got the following things that make a bullish move more likely:
According to seasonality, in the last 15 years, only in one year went the price down within the timespan from the 7th of May until the 23rd of June. So, it's a bullish time for this stock according to seasonality.
The prior inverse H/S...
good company that could be nearing a top in the short and long term. my weakness is getting squeezed on sub iv of 3s. Will this company get re-valued in amongst the others in tech?
Dexcom makes glucose monitoring systems for patients with diabetes. I don't see Americans getting healthier any time soon, so demand for the company's products should remain high for the foreseeable future.
The stock is just breaking out of a high tight flag pattern. Technically, a high tight flag requires a move up of 100% or more, so DXCM comes up a little...
I last spoke about DXCM when it just broke the $423.40 range and said it would take weeks to reach and challenge the all time highs.
Fast forward 3 weeks and here we are.
Trade idea:
* Look for buying opportunities in the $423.40 to $430 area
OR
* Wait for another weekly close above $456.23
ER coming up seems to be at top edge of megaphone..
can breakout big here or come back down inside the megaphone
ER can be a toss up..
overall bullish as it printed a new ATH right before the ER
DXCM has been in consolidation over the past year and within that it's been forming a smaller range since Feb of 2021.
The smaller range has broken out with a lot of buying pressure and is now testing the broken resistance as support.
Three things make this breakout significant.
1. It broke out with a lot of volume
2. It's retesting the broken resistance of...
The larger pattern appears to be ABC bullish .
If c is c, there could also be a smaller pattern inside the ABC pattern, a shark . The shark is labeled differently than the other harmonic patterns and begins with an O verse an X. C should land at the 1.13 fib level of OX. Like the Cypher , the 2nd peak is higher than the first peak. So you can really narrow down...
DXCM based on Elliott wave count is currently in wave 4 consolidation.
It is predicted the stock will move within the sideway range of USD298 and USD456.
For Options trader, Iron Condor strategy perhaps is one good strategy to consider for the trading opportunity.
Happy trading!
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.
NASDAQ
